VCAM1 and Duchenne muscular dystrophy: Additionally, DMD-iSkMs, B10-mdx, and D2-mdx mice were treated with a microdystrophin adeno-associated virus (AAV) to determine if HMGB1 or VCAM1 had potential as treatment-responsive biomarkers.